Form 8-K - Current report:
SEC Accession No. 0001213900-25-084303
Filing Date
2025-09-04
Accepted
2025-09-04 09:25:05
Documents
18
Period of Report
2025-08-28
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0255860-8k_pmgc.htm   iXBRL 8-K 30706
2 CERTIFICATE OF AMENDMENT FILED ON AUGUST 28, 2025 ea025586001ex3-1_pmgc.htm EX-3.1 8237
3 PRESS RELEASE DATED AUGUST 28, 2025 ea025586001ex99-1_pmgc.htm EX-99.1 11235
4 GRAPHIC ex3-1_001.jpg GRAPHIC 1075989
5 GRAPHIC ex3-1_002.jpg GRAPHIC 820543
6 GRAPHIC ex3-1_003.jpg GRAPHIC 801961
7 GRAPHIC ex3-1_004.jpg GRAPHIC 161197
  Complete submission text file 0001213900-25-084303.txt   4166747

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE elab-20250828.xsd EX-101.SCH 3026
9 XBRL LABEL FILE elab-20250828_lab.xml EX-101.LAB 34239
10 XBRL PRESENTATION FILE elab-20250828_pre.xml EX-101.PRE 22366
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0255860-8k_pmgc_htm.xml XML 3914
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 251292044
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)